Transistor Magia disprezzare camillo porta maugeri futuro Perdere Cordiali saluti
April 2020 Reviewer of the Month - Reviewer Name: European Urology
Immune-based combination therapy for metastatic kidney cancer | Nature Reviews Nephrology
Ecco il bracciale che aiuta i malati di tumore Parte da Pavia lo studio premiato in Europa - La Provincia Pavese
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all? - Porta - Annals of Translational Medicine
Numero 3, Luglio-Settembre - Azienda ospedaliera S.Camillo ...
Press & Media - Capable
Terapie di combinazione: il punto su melanoma, carcinoma polmonare e carcinoma renale - OncoInfo
Nicole Gri (@NikGri93) / Twitter
The role of endothelial colony forming cells in kidney cancer's pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review - ScienceDirect
Axitinib Did Not Meet Study End Point in mRCC, but Dosing Found Feasible - Cancer Therapy Advisor
maugeri - insalutenews.it
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas: Expert Opinion on Pharmacotherapy: Vol 21, No 18
Carcinoma renale avanzato: una terapia innovativa in prima linea - OncoInfo
Treatment sequencing strategies in metastatic renal cell carcinoma: A critical interpretation of available data - Mimma Rizzo, Matteo Santoni, Camillo Porta, 2020
Pavia, l'oncologia della Maugeri al top - Cronaca - ilgiorno.it
Camillio PORTA | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO) | Research profile
WHICH IMMUNOTHERAPY IS THE STANDARD 1ST LINE THERAPY IN mRCC – IMMUNE COMBOS WITH A TKI
Kidney Cancer: What Is New in the Second-Line Treatment Setting?
Mirrors of Medicine - PinPoint cases - Experten und Mitarbeiter
Untitled
Mirrors of Medicine - PinPoint cases - Esperti e collaboratori
PDF) Simian virus 40-like DNA sequences and large-T antigen-retinoblastoma family protein pRb2/p130 interaction in human mesothelioma
SV40 Replication in Human Mesothelial Cells Induces HGF/Met Receptor Activation: A Model for Viral-Related Carcinogenesis of Hum
2018 Impact Factor 17.298
COVID-19: il ruolo degli oncologi - OncoInfo
Frontiers | Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214 - European Urology